Patent · US Active

Compositions and methods relating to universal glycoforms for enhanced antibody efficacy

US10118969B2 · kind B2 · utility

11Cited by
194References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2016
Grant dateNov 6, 2018
Priority date
Expiry dateJan 30, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y302/01051
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to compositions and methods of use comprising antibodies or binding fragments thereof further comprising universal Fc glycoforms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.